← Leaderboards
Matthew Hohenboken
Nabi Biopharmaceuticals
$1,421,797
Attributed
$1,421,797
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,421,797 · 1
By mechanism
R01$1,421,797 · 1
Top collaborators
No co-investigators on record.
Most similar at Nabi Biopharmaceuticals
Same institution · by research overlap
- Ali I. Fattom$17,450,692
- David H. Malin$0
- Paul D Kessler$10,007,124
- Arjen De Vos$2,588,831
Others in their field
Top investigators on “Abstinence Syndrome”
- T John Winhusen · University Of Cincinnati$33,667,470
- Rebecca D Jackson · Ohio State University$29,698,788
- Abhik Das · Research Triangle Institute$25,628,714
- Barbara J Mason · Scripps Research Institute, The$13,231,132
- Hendree E. Jones · Johns Hopkins University$10,950,361
- Deepak Cyril D'souza · Va Connecticut Healthcare System$10,584,249
Research focus
Abstinence SyndromeAddictionAdultAdverse EventAlkaloidsAnimalsAntibodiesAttenuatedBaseBehavioralBinding (Molecular Function)Blood - Brain Barrier AnatomyBrainCarrier ProteinsCause Of DeathClinical TrialsClinical Trials, Phase IClinical Trials, Phase IiClinical Trials, Phase IiiConceptControlled Clinical TrialsCounselingDesignAbstinence